Mauro Passucci

6PUBLICATIONS
14CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Medical mycologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Feb 21, 2026
Prognostic impact of treatment-related and geriatric factors in older patients with classic Hodgkin lymphoma: A real-life cohort study.

Silvio Ligia, Giovanni Manfredi Assanto, Tania Soriano

|Apr 02, 2024
Fostamatinib combined with TPO-RAs or steroids as a bridge to monotherapy or as time-limited continuous treatment in relapsed chronic ITP: A single-centre case series.

Mauro Passucci, Alessandro Laganà, Livia Donzelli

|Feb 09, 2024
Neutrophil to lymphocyte ratio in myelofibrosis patients treated with ruxolitinib may predict prognosis and rate of discontinuation.

Alessandro Laganà, Mauro Passucci, Sara Pepe

|Dec 14, 2023
Early death risk score in acute promyelocytic leukemia: A retrospective analysis from a monocentric cohort.

Alessandro Costa, Ida Carmosino, Emilia Scalzulli

|Dec 05, 2023
Early clearance of hairy cell leukaemia in the bone marrow after first-line treatment with cladribine predicts a favourable outcome.

S Ligia, M Passucci, G M Assanto

|Jul 12, 2023
<i>CCND2</i> mutations in atypical chronic myeloid leukemia: a report of two cases.

Giovanni Iaquinta, Emilia Scalzulli, Silvia Angeloni

Pageof 1

Frequent Collaborators

3 joint publications

Massimo Breccia

2 joint publications

Silvio Ligia

2 joint publications

Giovanni Manfredi Assanto

2 joint publications

Ilaria Del Giudice